Diurnal variation of wearable device-based heart rate variability in the Chronic Renal Insufficiency Cohort study

Carsten Skarke1,2, Wei Yang3, Daohang Sha3

  • 1Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. cskarke@pennmedicine.upenn.edu.

NPJ Digital Medicine
|November 13, 2025
PubMed

Insights

Continuous wearable EKG monitoring in chronic kidney disease (CKD) reveals key factors influencing heart rate variability (HRV). Diabetes and higher proteinuria are linked to lower Standard Deviation of NN Intervals (SDNN), a vital HRV metric.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Prognostic value of continuous, out-of-clinic cardiovascular monitoring in chronic kidney disease (CKD) is under-explored.
  • Wearable technology offers novel methods for assessing cardiovascular function in CKD patients.

Purpose of the Study:

  • To evaluate the prognostic value of continuous, out-of-clinic biometric monitoring of cardiovascular function in CKD.
  • To identify clinical and demographic factors associated with heart rate variability (HRV) metrics in CKD patients.

Main Methods:

  • Collected approximately 50 hours of EKG recordings from 458 participants using wearable BioPatch devices across seven Chronic Renal Insufficiency Cohort centers.
  • Utilized multivariable linear regression to analyze associations between clinical factors and HRV metrics, specifically Standard Deviation of NN Intervals (SDNN).

Main Results:

  • Diabetes was significantly associated with a 7.4 ms lower SDNN compared to non-diabetic participants (p=0.001).
  • Higher proteinuria (uPCR ≥ 0.2) was associated with a 5.73 ms lower SDNN compared to lower proteinuria (p=0.027).
  • This study represents the largest dataset evaluating SDNN using wearable EKG technology in CKD.

Conclusions:

  • Specific clinical and demographic factors, including diabetes and proteinuria, significantly influence HRV in the CKD population.
  • These findings establish a foundation for investigating time-specific HRV metrics as potential predictive biomarkers for cardiovascular risk and clinical outcomes in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
338
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.5K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
783
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552